Novel therapies vs hematopoietic cell transplantation in myelofibrosis: who, when, how?

J England, V Gupta - Hematology, 2021 - ashpublications.org
Myelofibrosis is one of the classical Philadelphia chromosome–negative myeloproliferative
neoplasms characterized by progressive marrow failure and chronic inflammation …
被引用次数：9 相关文章
[HTML] nih.gov

[HTML][HTML] Novel therapies vs hematopoietic cell transplantation in myelofibrosis: who, when, how?

J England, V Gupta - Hematology: the American Society of …, 2021 - ncbi.nlm.nih.gov
Myelofibrosis is one of the classical Philadelphia chromosome–negative myeloproliferative
neoplasms characterized by progressive marrow failure and chronic inflammation …
[PDF] archive.org

[PDF][PDF] Novel ther a pies vs hema to poi etic cell trans plan ta tion in mye lo fibro sis: who, when, how?

J England, V Gupta - scholar.archive.org
Myelofibrosis (MF) encompasses a group of clonal stem cell dis or ders that are either pri
mary mye lo fibro sis or arise from a pre ced ing poly cy the mia vera (post-PV MF) or …

Novel therapies vs hematopoietic cell transplantation in myelofibrosis: who, when, how?

J England, V Gupta - Hematology. American Society of Hematology …, 2021 - europepmc.org
Myelofibrosis is one of the classical Philadelphia chromosome–negative myeloproliferative
neoplasms characterized by progressive marrow failure and chronic inflammation …

Novel therapies vs hematopoietic cell transplantation in myelofibrosis: who, when, how?

J England, V Gupta - Hematology. American Society of …, 2021 - pubmed.ncbi.nlm.nih.gov
Myelofibrosis is one of the classical Philadelphia chromosome-negative myeloproliferative
neoplasms characterized by progressive marrow failure and chronic inflammation …